Insider Transactions Reported by 16 Insiders of Armata Pharmaceuticals, Inc.

Symbol
ARMP on NYSE
Location
Los Angeles, CA

There are no Buy or Sell transactions made by insiders since 04 Jan 2025

Armata Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Deborah Birx Chief Executive Officer, Director $493,445 10 Jul 2025
Richard Rychlik Corporate Controller and PFO $50,000 14 Mar 2024
Pierre Kyme Chief Business Officer $20,457 14 Mar 2025
Innoviva, Inc. Director, 10%+ Owner 10 Jan 2023
Todd Patrick Director 13 Apr 2022
JOSEPH M. PATTI Director 05 Feb 2025
Jules Haimovitz Director 05 Feb 2025
Kostas D. Odysseas Director 05 Feb 2025
Duane Alfred Morris VP of Operations 13 Apr 2022
Brian Varnum President and CEO 13 Apr 2022
Robin Kramer Director 05 Feb 2025
Todd C. Peterson Director 05 Feb 2025
Julianne Averill Chief Financial Officer 02 May 2023
Erin Butler Vice President,Finance & Admin 01 Jul 2022
David Duane House SVP, Finance, and PFO 05 Feb 2025
Sarah Schlesinger Director 05 Feb 2025

Recent Insider Transactions by Companies or Individuals for Armata Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.